HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Carminomycin II

HCID 156955
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
50935-05-2
Standard SMILES
CC(=O)C1(O)Cc2c(O)c3c(c(O)c2C(OC2CC(N)C(OC(CC(C)O)OC(C)CO)C(C)O2)C1)C(=O)c1c(O)cccc1C3=O
InChIKey
DNHXZQIEIKSDIK-UHFFFAOYSA-N
Molecular formula
C33H41NO13
Average molar mass
659.7 g/mol
Monoisotopic mass
659.25779036

Overview

Carminomycin II is an anthracycline.

Names & identifiers

Preferred name
Carminomycin II
IUPAC
9-acetyl-7-[4-amino-5-[3-hydroxy-1-(1-hydroxypropan-2-yloxy)butoxy]-6-methyloxan-2-yl]oxy-4,6,9,11-tetrahydroxy-8,10-dihydro-7H-tetracene-5,12-dione
English name
D-326II
Molecular formula
C33H41NO13
Molecular weight
659.69

Names & synonyms

Carminomycin IIRefChem:918084Carminomicin 350935-05-2D-326II9-acetyl-7-[4-amino-5-[3-hydroxy-1-(1-hydroxypropan-2-yloxy)butoxy]-6-methyloxan-2-yl]oxy-4,6,9,11-tetrahydroxy-8,10-dihydro-7H-tetracene-5,12-dione50935-06-34-Hydroxybaumycin A14-Hydroxybaumycin A2Carminomicin 2Carminomicin III5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-acetyl-10-((3-amino-2,3,6-trideoxy-4-O-(3-hydroxy-1-(2-hydroxy-1-methylethoxy)butyl)-alpha-L-lyxo-hexopyranosyl)oxy)-1,6,8,11-tetrahydroxy-
Show more names
Rubeomycin ARubeomycin A1Antibiotic D-326IIAntibiotic FA-1180AAntibiotic FA-1180A15,12-Naphthacenedione, 8-acetyl-10-[[3-amino-2,3,6-trideoxy-4-O-[3-hydroxy-1-(2-hydroxy-1-methylethoxy)butyl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy- (9CI)
8-Acetyl-10-((3-amino-2,3,6-trideoxy-4-O-(3-hydroxy-1-(2-hydroxy-1-methylethoxy)butyl)-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-5,12-naphthacenedione5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-4-O-(3-hydroxy-1-(2-hydroxy-1-methylethoxy)butyl)-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-DTXSID30965214CHEBI:23124078919-32-178919-33-23-acetyl-3,5,10,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-4-O-{3-hydroxy-1-[(1-hydroxypropan-2-yl)oxy]butyl}hexopyranoside

Properties

Computed structural propertiesFilling in

XLogP
1.9
Topological polar surface area
236 Ų
Hydrogen bond donors
7
Hydrogen bond acceptors
14
Rotatable bonds
10
Heavy atoms
47
Formal charge
0
Complexity
1,160

Physicochemical properties

Boiling point
880.3 · 880.3±65.0 °C(Predicted)
Density
1.5 · 1.50±0.1 g/cm3(Predicted)
pka
6.46 · 6.46±0.60(Predicted)

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
50935-05-2、50935-06-3、78919-32-1、78919-33-2
PubChem CID
156955
DTXSID
DTXSID30965214
ChEBI
CHEBI:231240